289P Low risk febrile neutropenia: Does combined chemotherapy/immune checkpoint inhibitor necessitate a change in approach?
| Autor: | Weaver, J.M.J., Nagy, B., Raby, S., Coe, F., Knight, T., Bradwell, D., Lewis, A., Wilson, C., Armstronh, A.C., Clay, V., Cooksley, T. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S335-S336 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|